Cargando…
Erratum to delivery of vascular endothelial growth factor (VEGFC) via engineered exosomes improves lymphedema
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421940/ https://www.ncbi.nlm.nih.gov/pubmed/34532418 http://dx.doi.org/10.21037/atm-2021-22 |
Ejemplares similares
-
Delivery of vascular endothelial growth factor (VEGFC) via engineered exosomes improves lymphedema
por: Li, Bohan, et al.
Publicado: (2020) -
Risk Factors for Lymphedema after Thigh Sarcoma Resection and Reconstruction—Erratum
Publicado: (2022) -
Evidence Mapping of the Treatments for Breast Cancer–related Lymphedema: Erratum
Publicado: (2022) -
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
por: Szőke, Dániel, et al.
Publicado: (2021) -
Erratum to: Retrospective Analysis of First-Line Anti-Vascular Endothelial Growth Factor Treatment Patterns in Wet Age-Related Macular Degeneration
por: Johnston, Stephen S., et al.
Publicado: (2014)